Literature DB >> 20549504

USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers.

Shiva Akhavantabasi1, Hesna B Akman, Aysegul Sapmaz, Jennifer Keller, Elizabeth M Petty, Ayse E Erson.   

Abstract

USP32, on chromosomal band 17q23.1-17q23.2, is a highly conserved but uncharacterized gene that gave rise during evolution to a well-known hominoid-specific proto-oncogene, USP6. We investigated the expression profile of USP32 in human tissues and examined its functions to gain insight into this novel member of the well-conserved ubiquitination system. We detected ubiquitous USP32 expression across tissues and confirmed the predicted deubiquitination function owing to the presence of conserved peptidase signature aspargine, cysteine, histidine, and aspartic acid domains of ubiquitin-specific proteases. A Golgi localization of GFP-fused USP32 was detected by fluorescent protection assay and BODIPY-TR staining. In addition, stable silencing of USP32 caused a significant decrease in the proliferation and migration rate of cells. Based on these and the fact that USP32 maps to 17q23, which is commonly amplified in breast cancers, we analyzed USP32 expression in breast cancer cells. We detected high expression of USP32 in 50% (9 of 18) of breast cancer cell lines and 22% (9 of 41) of primary breast tumors compared to mammary epithelial cells. In summary, we report the preliminary characterization of this novel deubiquitinating enzyme on 17q23 and demonstrate its functional role in the ubiquitin system and its potential involvement in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549504     DOI: 10.1007/s00335-010-9268-4

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  37 in total

1.  Constitutive activation of pp125fak in newly isolated human breast cancer cell lines.

Authors:  K M Ignatoski; S P Ethier
Journal:  Breast Cancer Res Treat       Date:  1999-03       Impact factor: 4.872

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Deubiquitination, a new player in Golgi to endoplasmic reticulum retrograde transport.

Authors:  Mickaël Cohen; Françoise Stutz; Catherine Dargemont
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

4.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

5.  Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.

Authors:  Göran Jönsson; Tara L Naylor; Johan Vallon-Christersson; Johan Staaf; Jia Huang; M Renee Ward; Joel D Greshock; Lena Luts; Håkan Olsson; Nazneen Rahman; Michael Stratton; Markus Ringnér; Ake Borg; Barbara L Weber
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

6.  Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.

Authors:  F J Couch; X Y Wang; G J Wu; J Qian; R B Jenkins; C D James
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

7.  Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells.

Authors:  A E Erson; B L Niell; S K DeMers; J M Rouillard; S M Hanash; E M Petty
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

8.  Ubiquitin-specific proteases of Saccharomyces cerevisiae. Cloning of UBP2 and UBP3, and functional analysis of the UBP gene family.

Authors:  R T Baker; J W Tobias; A Varshavsky
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

9.  Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.

Authors:  S P Ethier; M L Mahacek; W J Gullick; T S Frank; B L Weber
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

10.  Copy number alterations that predict metastatic capability of human breast cancer.

Authors:  Yi Zhang; John W M Martens; Jack X Yu; John Jiang; Anieta M Sieuwerts; Marcel Smid; Jan G M Klijn; Yixin Wang; John A Foekens
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

View more
  22 in total

1.  ARID3B expression in primary breast cancers and breast cancer-derived cell lines.

Authors:  Ayse Selcen Oguz Erdogan; Nihan Ozdemirler; Merve Oyken; Murat Alper; Ayse Elif Erson-Bensan
Journal:  Cell Oncol (Dordr)       Date:  2014-08-14       Impact factor: 6.730

Review 2.  The role of deubiquitinases in breast cancer.

Authors:  Zhenna Xiao; Peijing Zhang; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

3.  Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer.

Authors:  Wenyu Hu; Haiyan Wei; Keming Li; Pei Li; Jiamao Lin; Rui Feng
Journal:  Cell Prolif       Date:  2017-06-09       Impact factor: 6.831

4.  ALCAM is indirectly modulated by miR-125b in MCF7 cells.

Authors:  H Begum Akman; S Duygu Selcuklu; Mark T A Donoghue; Shiva Akhavantabasi; Aysegul Sapmaz; Charles Spillane; M Cengiz Yakicier; A Elif Erson-Bensan
Journal:  Tumour Biol       Date:  2014-12-25

5.  ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.

Authors:  U-H Park; M-R Kang; E-J Kim; Y-S Kwon; W Hur; S K Yoon; B-J Song; J H Park; J-T Hwang; J-C Jeong; S-J Um
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

6.  Estrogen-induced upregulation and 3'-UTR shortening of CDC6.

Authors:  Begum H Akman; Tolga Can; A Elif Erson-Bensan
Journal:  Nucleic Acids Res       Date:  2012-09-12       Impact factor: 16.971

Review 7.  Deubiquitinases in cancer.

Authors:  Rongbin Wei; Xiaodong Liu; Weixin Yu; Tianshu Yang; Wenping Cai; Junjun Liu; Xiao Huang; Guo-tong Xu; Shouliang Zhao; Jianhua Yang; Shangfeng Liu
Journal:  Oncotarget       Date:  2015-05-30

Review 8.  Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancer.

Authors:  Anupama Pal; Nicholas J Donato
Journal:  Breast Cancer Res       Date:  2014       Impact factor: 6.466

Review 9.  The business of deubiquitination - location, location, location.

Authors:  Erin S Coyne; Simon S Wing
Journal:  F1000Res       Date:  2016-02-11

10.  Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse.

Authors:  Rabeah A Al-Temaimi; Tuan Zea Tan; Makia J Marafie; Jean Paul Thiery; Philip Quirke; Fahd Al-Mulla
Journal:  Int J Mol Sci       Date:  2016-04-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.